Research
Metabolic adaptation
GLP-1 RAs demonstrate multisystemic benefits including cardiovascular risk reduction and improved renal outcomes.
Incorporating GLP-1 RAs in treatment plans may enhance overall patient health beyond weight loss.
StrongSupportsmedium confidence
demonstrate multisystemic benefits including cardiovascular risk reduction, improved renal outcomes and treatment of metabolic-dysfunction-associated steatohepatitis.
Why this rating
The claim is based on a synthesis of current evidence presented in the review.
Source
Obesity management medications for the surgeon
Matthew Harris et al. · Frontline Gastroenterology · 2026
DOI 10.1136/flgastro-2025-103307
review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →